Cargando…

Decreased Expression of PACSIN1 in Brain Glioma Samples Predicts Poor Prognosis

Gliomas are the most severe brain tumours with a poor prognosis. Although surgery, postoperative radiotherapy and chemotherapy can improve the survival rate of glioma patients, the prognosis of most glioma patients is still poor. In recent years, the influence of gene-targeted therapy on gliomas has...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zimu, Zhou, Jia, Zhang, Xian, Fu, Rui, Ma, Yuting, Ren, Yuan, Wei, Tianhong, Wen, Mian, Ma, Yinlong, Liu, Enfang, Shan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Molecular Biosciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8375027/ https://www.ncbi.nlm.nih.gov/pubmed/34422904 http://dx.doi.org/10.3389/fmolb.2021.696072

Ejemplares similares

CD155 Overexpression Correlates With Poor Prognosis in Primary Small Cell Carcinoma of the Esophagus
por: Zhao, Kaikai, et al.
Publicado: (2021)

Molecular and Clinical Characterization of LIGHT/TNFSF14 Expression at Transcriptional Level via 998 Samples With Brain Glioma
por: Yang, Ying, et al.
Publicado: (2021)

Coexisting EGFR and TP53 Mutations in Lung Adenocarcinoma Patients Are Associated With COMP and ITGB8 Upregulation and Poor Prognosis
por: Zheng, Chang, et al.
Publicado: (2020)

A B7-CD28 Family-Based Signature Demonstrates Significantly Different Prognosis and Immunological Characteristics in Diffuse Gliomas
por: Deng, Xiangyang, et al.
Publicado: (2022)

A Low Advanced Lung Cancer Inflammation Index Predicts a Poor Prognosis in Patients With Metastatic Non–Small Cell Lung Cancer
por: Lu, Ping, et al.
Publicado: (2022)

Upregulation of GNPNAT1 Predicts Poor Prognosis and Correlates With Immune Infiltration in Lung Adenocarcinoma
por: Liu, Wenting, et al.
Publicado: (2021)

SMPDL3B Predicts Poor Prognosis and Contributes to Development of Acute Myeloid Leukemia
por: Qu, Huiqing, et al.
Publicado: (2021)

ELK1 Enhances Pancreatic Cancer Progression Via LGMN and Correlates with Poor Prognosis
por: Yan, Qiang, et al.
Publicado: (2021)

The Value of H2BC12 for Predicting Poor Survival Outcomes in Patients With WHO Grade II and III Gliomas
por: Zhou, Jie, et al.
Publicado: (2022)

Methylation and Expression of the Exercise-Related TLR1 Gene Is Associated With Low Grade Glioma Prognosis and Outcome
por: Lu, Lichun, et al.
Publicado: (2021)

Low Expression of RILPL2 Predicts Poor Prognosis and Correlates With Immune Infiltration in Endometrial Carcinoma
por: Liu, Jinhui, et al.
Publicado: (2021)

Upregulation of circ_0008812 and circ_0001583 predicts poor prognosis and promotes breast cancer proliferation
por: Lin, Hong, et al.
Publicado: (2022)

RNA m1A Methyltransferase TRMT6 Predicts Poorer Prognosis and Promotes Malignant Behavior in Glioma
por: Wang, Beibei, et al.
Publicado: (2021)

Characterization of METTL7B to Evaluate TME and Predict Prognosis by Integrative Analysis of Multi-Omics Data in Glioma
por: Chen, Xiaochuan, et al.
Publicado: (2021)

SEMA6B Overexpression Predicts Poor Prognosis and Correlates With the Tumor Immunosuppressive Microenvironment in Colorectal Cancer
por: Li, Tiegang, et al.
Publicado: (2021)

A cuproptosis-related lncRNAs signature for prognosis, chemotherapy, and immune checkpoint blockade therapy of low-grade glioma
por: Yan, Xiuwei, et al.
Publicado: (2022)

A novel necroptosis-related gene signature for predict prognosis of glioma based on single-cell and bulk RNA sequencing
por: Guo, Kai, et al.
Publicado: (2022)

High CTC-TRPC5 Expression Significantly Associated With Poor Prognosis in Radical Resected Colorectal Cancer Patients
por: Cai, Dongyan, et al.
Publicado: (2021)

High Expression of Long Non-Coding RNA TMCO1-AS1 is Associated With Poor Prognosis of Hepatocellular Carcinoma
por: Huang, Xuelian, et al.
Publicado: (2022)

Co-Overexpression of GRK5/ACTC1 Correlates With the Clinical Parameters and Poor Prognosis of Epithelial Ovarian Cancer
por: Liu, Longyang, et al.
Publicado: (2022)

Identification of Down-Regulated ADH1C is Associated With Poor Prognosis in Colorectal Cancer Using Bioinformatics Analysis
por: Li, Ming, et al.
Publicado: (2022)

Machine learning-based screening of an epithelial-mesenchymal transition-related long non-coding RNA signature reveals lower-grade glioma prognosis and the tumor microenvironment and predicts antitumor therapy response
por: Wang, Nan, et al.
Publicado: (2022)

Comprehensive Molecular Analyses of a Novel Mutational Signature Classification System with Regard to Prognosis, Genomic Alterations, and Immune Landscape in Glioma
por: Liu, Zaoqu, et al.
Publicado: (2021)

Stromal protein CCN family contributes to the poor prognosis in lower-grade gioma by modulating immunity, matrix, stemness, and metabolism
por: Liu, Zhihui, et al.
Publicado: (2022)

Integrative Genomic and Transcriptomic Analysis of Primary Malignant Gliomas Revealed Different Patterns Between Grades and Somatic Mutations Related to Glioblastoma Prognosis
por: Jin, Huawei, et al.
Publicado: (2022)

CORO1C is Associated With Poor Prognosis and Promotes Metastasis Through PI3K/AKT Pathway in Colorectal Cancer
por: Wang, Zongxia, et al.
Publicado: (2021)

High Expression of Plasma Extracellular HSP90α is Associated With the Poor Efficacy of Chemotherapy and Prognosis in Small Cell Lung Cancer
por: Huang, Baoyue, et al.
Publicado: (2022)

Comprehensive Analysis of HDAC Family Identifies HDAC1 as a Prognostic and Immune Infiltration Indicator and HDAC1-Related Signature for Prognosis in Glioma
por: Fan, Yuxiang, et al.
Publicado: (2021)

Corrigendum: CORO1C is Associated with Poor Prognosis and Promotes Metastasis Through PI3K/AKT Pathway in Colorectal Cancer
por: Wang, Zongxia, et al.
Publicado: (2021)

The High Ratio of the Plasma miR-96/miR-99b Correlated With Poor Prognosis in Patients With Metastatic Colorectal Cancer
por: Chen, Yi, et al.
Publicado: (2022)

MAP3K8 Is a Prognostic Biomarker and Correlated With Immune Response in Glioma
por: Ren, Jing, et al.
Publicado: (2021)

High C1QTNF1 expression mediated by potential ncRNAs is associated with poor prognosis and tumor immunity in kidney renal clear cell carcinoma
por: Qiu, Jiechuan, et al.
Publicado: (2023)

Effective TME-related signature to predict prognosis of patients with head and neck squamous cell carcinoma
por: Wan, Lingfei, et al.
Publicado: (2023)

Novel TrxR1 Inhibitors Show Potential for Glioma Treatment by Suppressing the Invasion and Sensitizing Glioma Cells to Chemotherapy
por: Jovanović, Mirna, et al.
Publicado: (2020)

Tumor Microenvironment Heterogeneity-Based Score System Predicts Clinical Prognosis and Response to Immune Checkpoint Blockade in Multiple Colorectal Cancer Cohorts
por: Wang, Hufei, et al.
Publicado: (2022)

Identification of HOXA1 as a Novel Biomarker in Prognosis of Head and Neck Squamous Cell Carcinoma
por: Li, Hui, et al.
Publicado: (2021)

Tumor Microenvironment Characteristics of Pancreatic Cancer to Determine Prognosis and Immune-Related Gene Signatures
por: Zhang, Congjun, et al.
Publicado: (2021)

Development of Personalized Signature Based on the Immune Landscape to Predict the Prognosis of Osteosarcoma and the Response to Immunotherapy and Targeted Therapy
por: Feng, Xiaofei, et al.
Publicado: (2022)

CD74 Correlated With Malignancies and Immune Microenvironment in Gliomas
por: Xu, Shengchao, et al.
Publicado: (2021)

FOXM1/lncRNA TYMSOS/miR-214-3p–Mediated High Expression of NCAPG Correlates With Poor Prognosis and Cell Proliferation in Non–Small Cell Lung Carcinoma
por: Yuan, Yixiao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_b07b5d771tiuua44i4mdaka9hp